The board of Arcam applies for de-listing and GE initiates compulsory redemption

On 27 December 2017, Arcam AB (publ) (“Arcam”), announced information regarding GE Sweden Holdings AB (“GE“) acquisition of additional shares in Arcam. Following completion of the acquisition GE has been registered as shareholders in the share register of Arcam of the acquired shares and holds app. 95 percent of the shares and votes in Arcam. GE has informed Arcam’s board of directors that GE has resolved to call for a compulsory redemption of the remaining shares in Arcam.

Considering the above, Arcam’s board of directors makes the assessment that circumstances for a well functional and satisfactory trading in the company's shares no longer exist. Accordingly, the board of directors of Arcam has applied for de-listing of the company's shares from Nasdaq Stockholm. Nasdaq Stockholm has approved the application and resolved that the last day of trading in the Arcam share will be Friday, January 26, 2018. 

For further information:

Magnus René, CEO and President, Arcam
Cell: +46 702 79 89 99 or +1 781 266 6957
E-mail: [email protected]

Arcam, a GE Additive company, brings together best-in-class Additive Manufacturing systems, the highest quality materials and real-world production expertise, changing the way manufacturers conceive and produce metal components. Together we use our collective knowledge to inspire and disrupt conventional thinking. Through our solution orientation, Arcam is an innovative partner for advanced manufacturing, primarily in the aerospace and medical industries.

Arcam Group provides Electron Beam Melting systems through Arcam EBM in Sweden and powder metals through AP&C in Canada.

________________________________________________________________________________________

Arcam AB • Krokslätts Fabriker 27A • SE-431 37 Mölndal, Sweden

Tags:

Powered by WPeMatico

You might like

About the Author: Erin Phan

Erin Phan Is a researcher and law student at York University (TORONTO). She has worked as the Director of the Graduate Lawyering Program. She worked for American law firms in Moscow, Russia for three years. Hegraduated from Columbia Law School, Columbia School of International and Public Affairs and Harvard College. She research interest is in human rights and health law, with a particular focus on the law and policy of vaccination.
%d bloggers like this: